Lundbeck. The pharmaceutical sector is trading at a 15-year-low, as the majors are plagued with patent expiries and more aggressive pricing regimes. Lundbeck benefits from a reasonably young portfolio of drugs that play well to current demographic trends - focussing on Alzheimer's, depression and Parkinson's disease, which should have above average growth rates.
| Sedol |
Type |
Price |
Date |
| 7085259 |
Buy |
DKK 144.38 |
31/10/2007 | |
